ArticleAging clinical and experimental research2020

Serum sclerostin and adverse outcomes in elderly patients with stable coronary artery disease undergoing percutaneous coronary intervention.

Wuyang He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.